LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...

from a naturalistic study on a large sample of inpatients with major
depression. J Affect Disord 115: 439–449
Höhl W (2009): Unterstützte Beschäftigung seit 2009 gesetzlich verankert.
Ergotherapie & Rehabilitation 4: 27–28
Höhl W (2009): Das WORK READINESS PROGRAM – Ein Therapieprogramm
auf der Grundlage des Modells der Menschlichen Betätigung
(MOHO). Ergotherapie & Rehabilitation 12: 31–34
Jäger M, Riedel M, Schmauß M, Laux G, Pfeiffer H, Naber D, Schmidt
LG, Gaebel W, Klosterkoetter J, Heuser I, Kühn KU, Lemke M,
Rüther E, Buchkremer G, Gastpar M, Bottlender R, Strauß A, Möller
HJ (2009): Prediction of symptom remission in schizophrenia
during inpatient treatment. World J Biol Psychiatry 10: 426–434
Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel
W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Degner D,
Buchkremer G, Gastpar M, Möller HJ, Riedel M (2009): Early improvement
as a predictor of remission and response in schizophrenia:
Results from a naturalistic study. Eur Psychiatry 24: 501–506
Janssen B, Ludwig S, Eustermann H, Menke R, Haerter M, Berger M,
Adam G, Seemann U, Kissling W, Gaebel W (2009): Improving outpatient
treatment in schizophrenia: Effects of computerized guideline
implementation – results of a multicenter- study within the
German Research Network on Schizophrenia. Eur Arch Psychiatry
Clin Neurosci 260: 51–57
Kircher T, Thienel R, Wagner M, Reske M, Habel U, Kellermann T,
Frommann I, Schwab S, Wölwer W, von Wilmsdorff M, Braus DF,
Schmitt A, Rapp A, Stöcker T, Jon Shah N, Henn FA, Sauer H, Gaebel
W, Maier W, Schneider F (2008): Neuregulin 1 ICE-Single Nucleotide
Polymorphism in First Episode Schizophrenia Correlates
with Cerebral Activation in Fronto-Temporal Areas. EurArch Psychiatry
Clin Neurosci 259: 72–79
Kissling W, Gaebel W, Naber D (2009): Statement zur CONSTAtre-
Studie. Schizophrenie. Zeit zum Umdenken in der Schizophrenietherapie.
Nervenarzt (in press)
Klafki HW, Lewczuk P, Kamrowski-Kruck H, Maler JM, Müller K,
Peters O, Heuser I, Jessen F, Popp J, Frölich L, Wolf S, Prinz B,
Luckhaus C, Schröder J, Pantel J, Gertz HJ, Kölsch H, Müller BW,
Esselmann H, Bibl M, Kornhuber J, Wiltfang J (2009): Measurement
of ERK 1/2 in CSF from patients with neuropsychiatric disorders
and evidence for the presence of the activated form. J Alzheimers
Dis Jul 20 (Epub ahead of print)
Klingberg S, Wittorf A, Bechdolf A, Herrlich J, Kircher T, König HH,
Müller B, Sartory G, Wagner M, Wiedemann G, Wölwer W, Buchkremer
G (2009): Psychotherapieforschung zur Kognitiven Verhaltenstherapie
bei Positiv-Symptomen psychotischer Störungen. Psychotherapie
Psychosomatik Medizinische Psychologie 59: 141–148
Klingberg S, Wittorf A, Herrlich J, Wiedemann G, Meisner C, Buchkremer
G, Frommann N, Wölwer W (2009): Cognitive Behavioural
Treatment of negative symptoms in schizophrenia patients – study
design of the TONES study, feasibility and safety of treatment. Eur
Arch Psychiat Clin Neurosc 259 (Suppl 2): 149–154
ReseaRch
Konrad A, Vucurevic G, Musso F, Stoeter P, Dahmen N, Winterer G
(2009): ErbB4 genotype predicts left frontotemporal structural
connectivity in human brain. Neuropsychopharmacology 3: 641–65
Kornhuber J, Schmidtke K, Frölich L, Perneczky R, Wolf S, Hampel
H, Jessen F, Heuser I, Peters O, Weih M, Jahn H, Luckhaus C, Hüll
M, Gertz HJ, Schröder J, Pantel J, Rienhoff O, Seuchter SA, Rüther
E, Henn F, Maier W, Wiltfang J (2009): Early and differential diagnosis
of dementia and mild cognitive impairment. Dement Gereatr
Cogn Disord 27: 404–417
Kotrotsios G, Cordes J, Canales EM, Kahl KG (2009): Metabolische
Risiken in der Behandlung der Schizophrenie. Adipositas 3: 71–76
Kuhn J, Gaebel W, Klosterkoetter J, Woopen C (2009): Deep brain stimulation
as a new therapeutic approach in therapy-resistant mental
disorders: ethical aspects ofinvestigational treatment. Eur Arch
Psychiatry Clin Neurosci 259 (Suppl): 135–141
Lange-Asschenfeldt C, Grohmann R, Lange-Asschenfeldt B, Engel R,
Rüther E, Cordes J (2009): Cutaneous adverse reactions to psychotropic
drugs: data from AMSP Multicenter Surveillance Program. J
Clin Psychiatr 70: 1258–1265
Lewczuk P, Kornhuber J, Vanmechelen E, Peters O, Heuser I, Maier
W, Jessen F, Bürger K, Hampel H, Frölich L, Henn F, Falkai P,
Rüther E, Jahn H, Luckhaus C, Perneczky R, Schmidtke K, Schröder
J, Kessler H, Pantel J, Gertz HJ, Vanderstichele H, de Meyer G,
Shapiro F, Wolf S, Bibl M, Wiltfang J (2009): Amyloid beta peptides
in plasma in early diagnosis of Alzheimer‘s disease: A multicenter
study with multiplexing. Exp Neurol 2009 Aug 5 (in press)
Luckhaus C (2009): Cerebral grey and white matter changes in mild
cognitive impairment and Alzheimer’s disease. Eur J Neurol 16:
438–439
Luckhaus C, Mahabadi B, Grass-Kapanke B, Jänner M, Willenberg H,
Jäger M, Supprian T, Fehsel K (2009): Blood serum levels of biochemical
markers of osteoporosis in mild cognitive impairment
and Alzheimer’s disease. J Neural Transm 116: 905–911
Mittrach M, Thünker J, Winterer G, Agelink MW, Regenbrecht G,
Arends M, Mobascher A, Kim SJ, Wölwer W, Brinkmeyer J, Gaebel
W, Cordes J (2009): The tolerability of repetitive transcranial magnetic
stimulation (rTMS) in schizophrenia with respect to cognitive
function. Psychopharmacopsychiatry, accepted 2009
Mobascher A, Arends M, Eschweiler GW, Brinkmeyer J, Agelink MW,
Kornischka J, Winterer G, Cordes J (2009): Biological correlates of
prefrontal activating and temporoparietal inhibiting treatment with
repetitive transcranial magnetic stimulation (rTMS). Fortschr
Neurol Psychiatr 77: 432–443
Mobascher A, Brinkmeyer J, Warbrick T, Musso F, Wittsack HJ, Saleh
A, Schnitzler A, Winterer G (2009): Laser-evoked potential P2
singel-trial amplitudes covary with the fMRI BOLD response in the
medial pain system and interconnected subcortical structures.
Neuroimage 45: 917–926
Mössner R, Schuhmacher A, Kühn K, Cvetanovska G, Rujescu D, Zill
P, Quednow BB, Rietschel M, Wölwer W, Gaebel W, Wagner M,
Maier W (2009): A functional serotonin 1A receptor variant influen-
135